Wikidata

(Q39850335)

English

Erlotinib and bevacizumab have synergistic activity against melanoma

scientific article

In more languages

Statements

title
Erlotinib and bevacizumab have synergistic activity against melanoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
author name string
Nikolaus Schicher
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Verena Paulitschke
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Alexander Swoboda
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Rainer Kunstfeld
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Robert Loewe
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Peter Pilarski
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Hubert Pehamberger
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
Christoph Hoeller
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
publication date
15 May 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017
page(s)
3495-3502
1 reference
stated in
Europe PubMed Central
PubMed ID
19447871
retrieved
15 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39850335&oldid=2091485322"